Different subgroups regarding the absence of rescue therapy in intravenous immunoglobulin-resistant Kawasaki disease

T. Nakada
{"title":"Different subgroups regarding the absence of rescue therapy in intravenous immunoglobulin-resistant Kawasaki disease","authors":"T. Nakada","doi":"10.9790/3013-068014047","DOIUrl":null,"url":null,"abstract":"The objective of this study is the description of clinical outcomes regarding the absence of rescue therapy of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease. I investigated the clinical outcomes of 33 IVIG-resistant patients who received the initial single IVIG therapy with the delayed use of anti- inflammatory drugs (DUA). These patients were divided into two groups: 11 patients who received rescue therapies (rescue group) and 22 patients who did not receive rescue therapy (non-rescue group). One patient of rescue group developed coronary artery lesions (CAL). None of the patients of non-rescue group developed CAL. The prevalence of persistent fever between rescue and non-rescue groups at 3 days and 4 days after initial IVIG therapy was 100% vs. 77% ( P = 0.144 ) and 100% vs. 18% ( P < 0.001 ), respectively. The C-reactive protein value, neutrophil counts, serum albumin levels, and sodium levels were significantly different between two groups at median 3 days after initial IVIG therapy. Two-thirds of the IVIG-resistant patients diagnosed at 24 h after completion of the initial IVIG therapy with DUA did not develop CAL after 30 days of illness without rescue therapies. The rescue therapy at this time may lead to overtreatment.","PeriodicalId":14540,"journal":{"name":"IOSR Journal of Pharmacy","volume":"21 1","pages":"40-47"},"PeriodicalIF":0.0000,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IOSR Journal of Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9790/3013-068014047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The objective of this study is the description of clinical outcomes regarding the absence of rescue therapy of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease. I investigated the clinical outcomes of 33 IVIG-resistant patients who received the initial single IVIG therapy with the delayed use of anti- inflammatory drugs (DUA). These patients were divided into two groups: 11 patients who received rescue therapies (rescue group) and 22 patients who did not receive rescue therapy (non-rescue group). One patient of rescue group developed coronary artery lesions (CAL). None of the patients of non-rescue group developed CAL. The prevalence of persistent fever between rescue and non-rescue groups at 3 days and 4 days after initial IVIG therapy was 100% vs. 77% ( P = 0.144 ) and 100% vs. 18% ( P < 0.001 ), respectively. The C-reactive protein value, neutrophil counts, serum albumin levels, and sodium levels were significantly different between two groups at median 3 days after initial IVIG therapy. Two-thirds of the IVIG-resistant patients diagnosed at 24 h after completion of the initial IVIG therapy with DUA did not develop CAL after 30 days of illness without rescue therapies. The rescue therapy at this time may lead to overtreatment.
关于静脉免疫球蛋白抵抗性川崎病缺乏抢救治疗的不同亚组
本研究的目的是描述静脉免疫球蛋白(IVIG)耐药川崎病缺乏抢救治疗的临床结果。我调查了33例最初接受单一IVIG治疗并延迟使用抗炎药物(DUA)的IVIG耐药患者的临床结果。将患者分为两组:接受抢救治疗的患者11例(抢救组)和未接受抢救治疗的患者22例(非抢救组)。抢救组1例出现冠状动脉病变(CAL)。非抢救组患者均未发生CAL。IVIG治疗后第3天和第4天,抢救组和非抢救组患者持续发热的发生率分别为100%∶77% (P = 0.144)和100%∶18% (P < 0.001)。初始IVIG治疗后中位3天,两组患者的c反应蛋白值、中性粒细胞计数、血清白蛋白水平和钠水平均有显著差异。三分之二的IVIG耐药患者在完成初始IVIG DUA治疗24小时后诊断,在没有抢救治疗的情况下,30天后没有发生CAL。此时的抢救治疗可能会导致过度治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信